Drug Repurposing
eBook - ePub

Drug Repurposing

  1. 332 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Drug Repurposing

About this book

Drug repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore represent wasted effort, it is an attractive as well as inherently more efficient process. Three repurposed drugs can be brought to market for the same cost as one new chemical entity; and they can also be identified more quickly, an important benefit for patients whose diseases are progressing faster than therapeutic innovation. But repurposing also requires a fresh look at configuring pharmaceutical R&D, considering clinical, regulatory and patent issues much earlier than would otherwise be the case; a holistic gedanken experiment almost needs to be undertaken at the very start of any repurposing development. In addition to new ways of thinking, the discovery of repurposing opportunities can take advantage of artificial intelligence techniques to match the perfect new use for an existing drug. And while repurposing of medicines has been in the mind of every doctor since Hypocrates, modern clinical practice will simply have to adapt to new repurposing techniques in an age where the number of known diseases is increasing much faster than the healthcare dollars available.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Drug Repurposing by David Cavalla in PDF and/or ePUB format, as well as other popular books in Medizin & Pharmakologie. We have over one million books available in our catalogue for you to explore.

Information

Edition
1
Topic
Medizin

Table of contents

  1. Cover
  2. Title
  3. Copyright
  4. Contents
  5. Chapter 1 Introduction and Historical Overview of Drug Repurposing Opportunities
  6. Chapter 2 Role of Academia: Drug Repurposing to Induce Autophagy for Treatment of Neurodegenerative Diseases
  7. Chapter 3 The Role of Clinical Medicine
  8. Chapter 4 Role of Industry
  9. Chapter 5 Collaboration Models for Repurposing
  10. Chapter 6 Screening Technologies
  11. Chapter 7 Cheminformatics Data Mining and Modeling for Drug Repurposing
  12. Chapter 8 Using Artificial Intelligence for Drug Repurposing
  13. Chapter 9 Field Discoveries (Case Reports)
  14. Chapter 10 Preclinical. A Repurposed Novel Lyn Kinase Activator, MLR-1023, is a Model Example of Pharmacological Pleiotropy
  15. Chapter 11 Harnessing the Potential of Early Access: Advancing Timely Patient Access to Innovative Medicines in a Sustainable Way
  16. Chapter 12 Adapting Payers’ and Producers’ Incentives to Drug Repurposing
  17. Chapter 13 Intellectual Property Considerations
  18. Chapter 14 Regulatory Considerations and Strategies for Drug Repositioning
  19. Chapter 15 Future Perspectives in Drug Repurposing
  20. Subject Index